FN1 and myeloid sarcoma: Combined with the evidence from other groups demonstrating vitronectin and fibronectin deposition in demyelinated lesions in the brains of MS patients [12-14] and EAE mice [15], this supports the hypothesis that fibronectin and vitronectin promote microglial activation in vivo.